Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients
Daniela Berg(Christian-Albrechts-Universität zu Kiel), Olaf Rieß(University of Tübingen), Marc Niwar(University of Tübingen), J. Carsten Möller(Philipps University of Marburg), Ted M. Dawson(Johns Hopkins University), Christine Klein(University of Lübeck), Sylvia Maaß(German Center for Neurodegenerative Diseases), Alexander Zimprich(Ludwig-Maximilians-Universität München), Thomas Müller(Ruhr University Bochum), Bernd Janetzky(Technische Universität Dresden), Eng‐King Tan(SingHealth), Laura Marsh(Michael E. DeBakey VA Medical Center), Dirk Woitalla(Ruhr University Bochum), Thomas Gasser(Hertie Institute for Clinical Brain Research), Peter P. Pramstaller(Eurac Research), Tanja Schmitz‐Hübsch(University of Bonn), Vladimir Kostić(University of Belgrade), Lüdger Schöls(German Center for Neurodegenerative Diseases), Peter Bauer(Centogene (Germany)), Ullrich Wuellner(University of Bonn), Rejko Krüger(Centre Hospitalier de Luxembourg), Wolfgang H. Oertel(Philipps University of Marburg)
Cited by 75
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Mortality after surgery in Europe: a 7 day cohort study
|The Lancet|2012|1.4k